(NYSE: CBT) Cabot's forecast annual revenue growth rate of 1.24% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Cabot's revenue in 2025 is $3,713,000,000.On average, 6 Wall Street analysts forecast CBT's revenue for 2026 to be $191,969,658,104, with the lowest CBT revenue forecast at $180,966,712,696, and the highest CBT revenue forecast at $205,405,947,208. On average, 6 Wall Street analysts forecast CBT's revenue for 2027 to be $197,576,928,360, with the lowest CBT revenue forecast at $186,626,881,728, and the highest CBT revenue forecast at $211,171,913,792.
In 2028, CBT is forecast to generate $204,030,579,032 in revenue, with the lowest revenue forecast at $197,788,523,464 and the highest revenue forecast at $212,388,585,640.